IMPORTANT NOTICE

This Copyright and DMCA Policy ("Policy") describes the policies and procedures of The Senior Wellness Company, as the operator of MedQuiry ("MedQuiry," "we," "our," or "us"), concerning copyright, intellectual property rights, notifications of claimed copyright infringement, counter-notifications, and related matters arising from access to or use of the MedQuiry websites, hosted platform, applications, application programming interfaces, stored-study and Personal Locker functionality, scoring services, reports, documentation, and related products and services (collectively, the "Services"). MedQuiry is a service operated by The Senior Wellness Company.

MedQuiry respects the intellectual property rights of authors, researchers, publishers, journals, institutions, users, and other rights holders. Users of the Services are required to do the same.

This Policy should be read together with the MedQuiry Terms of Service (the "Terms"), Privacy Policy (the "Privacy Notice"), Acceptable Use Policy, API Terms of Use, and any applicable Enterprise License Agreement, Order Form, data-processing agreement, or other agreement governing use of the Services (collectively, the "Agreement"). This Policy supplements Article 13 of the Terms. The relationship among these documents is addressed in Section 18.

Capitalized terms not defined in this Policy have the meanings assigned to them in the applicable Agreement. "User Content" includes the submitted materials described in Article 11 of the Terms and materials called "Customer Content" in an applicable enterprise or API agreement. "Stored Study PDF" means an uploaded study PDF retained through authorized locker, repository, account, project, or similar storage functionality. References to "Results" include MedQuiry Scores and Analytical Outputs; "API Outputs" retains its meaning under the applicable API agreement. These references do not modify ownership, license rights, or separately negotiated definitions.

This Policy is intended, among other things, to establish procedures relating to notifications and counter-notifications under the Digital Millennium Copyright Act, 17 U.S.C. § 512 ("DMCA"), where applicable.

Nothing in this Policy constitutes a representation or warranty that any particular activity, material, function, or aspect of the Services qualifies for a limitation of liability or safe harbor under the DMCA or any other law.

1. RESPECT FOR INTELLECTUAL PROPERTY RIGHTS

MedQuiry respects copyrights and other intellectual property rights.

You may use the Services only with materials that you are legally authorized to submit, store, process, access, copy, transmit, or otherwise use in connection with the Services.

You must not use the Services to infringe or facilitate infringement of another person's or entity's:

• copyright;
• trademark;
• trade secret;
• database right;
• publication or licensing right;
• contractual right;
• moral right;
• right of attribution; or
• other intellectual property or proprietary right.

Nothing in this Policy is intended to restrict lawful fair use, licensed use, public-domain use, or any other use permitted by applicable law.

2. PUBLISHED STUDIES AND THIRD-PARTY MATERIALS

MedQuiry analyzes published medical and scientific research. Research studies and other materials processed through the Services may be protected by copyright or other intellectual property rights owned by authors, publishers, journals, institutions, licensors, or other third parties.

The inclusion, identification, retrieval, submission, storage, processing, analysis, scoring, citation, or reference to a publication through the Services does not transfer ownership of that publication to MedQuiry.

Copyright and other intellectual property rights in third-party publications remain with their respective rights holders.

MedQuiry's analysis or scoring of a publication does not constitute a claim by MedQuiry that it owns, publishes, distributes, licenses, sponsors, or endorses the underlying publication.

References within the Services to third-party publications, authors, journals, publishers, trademarks, databases, or other sources are for identification, analytical, informational, or research purposes and do not imply affiliation, sponsorship, approval, or endorsement unless MedQuiry expressly states otherwise.

3. USER-SUBMITTED AND STORED MATERIALS

The Services may permit users to submit or provide research studies and other materials through methods including:

• uploading a study PDF or other supported file;
• submitting a Digital Object Identifier ("DOI");
• submitting a PubMed Identifier ("PMID");
• providing another supported citation or identifier;
• using an authorized API or integration; or
• using other submission methods made available through the Services.

When you upload a study PDF for scoring through an individual account, MedQuiry retains it and automatically stores it in the Personal Locker associated with your account so that it remains available to you through the Services. API and enterprise submissions may be retained through the authorized locker, repository, account, project, or similar storage functionality made available under the applicable Agreement. The Personal Locker must not be used as a general-purpose file-storage service or to store prohibited material.

You remain responsible for materials that you submit or direct MedQuiry to retrieve, including while those materials remain stored through the Services.

By submitting material to the Services, you represent and warrant that you own, control, license, or otherwise possess all rights, permissions, authorizations, consents, and lawful bases necessary for MedQuiry to receive, host, store, reproduce, access, process, analyze, copy, transmit, retrieve, transform, and otherwise use the material as contemplated by the Agreement.

Contractual permission to use submitted material does not itself establish a lawful basis for processing personal data or replace notices, consents, or other requirements imposed by applicable data-protection law. Publication of a study does not establish authority to submit patient-identifiable information, protected health information, confidential clinical records, or other prohibited information. Any proposed exception must satisfy the express requirements of the applicable Agreement before processing begins; this Policy creates no such exception.

You must not submit or store material if doing so, or MedQuiry's processing of the material as contemplated by the Agreement, would violate:

• copyright or other intellectual property law;
• a publisher or database license;
• institutional access restrictions;
• subscription or publication terms;
• contractual restrictions;
• confidentiality obligations; or
• other applicable legal obligations.

Acceptance, storage, processing, or scoring of submitted material does not constitute MedQuiry's determination that the submission or use is authorized or lawful.

MedQuiry does not undertake to verify the copyright or licensing status of every study or other material submitted by a user.

4. MEDQUIRY'S LIMITED RIGHTS IN SUBMITTED MATERIALS

Submission or storage of a publication through the Services does not transfer ownership of the publication to MedQuiry.

Rights granted to MedQuiry in User Content or Customer Content are limited to the rights described in the applicable Agreement.

MedQuiry may receive, host, store, reproduce, access, process, analyze, copy, transmit, retrieve, transform, or otherwise use submitted material only within the limited rights granted under the applicable Agreement. Sections 11.2 and 11.6 of the Terms and Section 9 of the API Terms, where applicable, govern those rights. Within that authorized scope, purposes may include:

1. performing scoring, analysis, or other functionality requested or initiated by the user or customer;

1. retaining and making an uploaded study PDF available through authorized Personal Locker, account, repository, project, or similar functionality;

1. providing support requested by the user or customer;

1. operating, securing, maintaining, auditing, and administering the Services only within the limited purposes authorized by the applicable Agreement;

1. investigating fraud, misuse, security incidents, or disputes;

1. complying with applicable law or legal process; and

1. enforcing the Agreement.

MedQuiry does not use submitted or stored study contents to train, fine-tune, or improve its scoring rubric, scoring model, or artificial intelligence models, and does not authorize service providers to use those contents for general-purpose model training. MedQuiry does not use stored studies for its own independent research, product development, benchmarking, dataset creation, licensing, commercialization, or analyses not requested or authorized by the user or customer. Submission, storage, or this Policy does not create broader rights in study contents.

These limitations do not prevent uses of non-content operational information, independently obtained public materials, synthetic data, authorized testing materials, or user Feedback permitted by the Terms and Privacy Notice. Study text may be transmitted to authorized service providers only as necessary for requested functionality and related security, integrity, quality-assurance, and legal-compliance functions, subject to the applicable Agreement, data-processing terms, and mandatory law.

5. DESIGNATED DMCA AGENT

Notifications of claimed copyright infringement under the DMCA should be directed to MedQuiry's designated agent:

Designated Copyright Agent

Richard O'Neill

The Senior Wellness Company

MedQuiry

P.O. Box 24

Califon, New Jersey 07830

Telephone: 908-391-4356

Email: copyright@medquiry.com

General legal correspondence that does not constitute a DMCA notification may be sent to legal@medquiry.com.

Sending a communication to another MedQuiry employee, contractor, email address, support channel, or business contact may not constitute effective delivery to MedQuiry's designated agent for purposes of the DMCA.

6. NOTIFICATION OF CLAIMED COPYRIGHT INFRINGEMENT

If you are a copyright owner or are authorized to act on behalf of a copyright owner and believe that material residing on or accessible through the Services infringes an exclusive right under copyright law, you may submit a written notification of claimed infringement to MedQuiry's designated agent.

To be effective under 17 U.S.C. § 512(c)(3), a notification should include substantially all of the following:

1. Signature. A physical or electronic signature of the copyright owner or a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.

2. Identification of the copyrighted work. Identification of the copyrighted work claimed to have been infringed or, if multiple copyrighted works at a single online site are covered by one notification, a representative list of those works at that site.

3. Identification of the allegedly infringing material. Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that the complaining party requests be removed or have access disabled, together with information reasonably sufficient to permit MedQuiry to locate the material. Because material may be stored privately within an account or Personal Locker rather than displayed on a publicly accessible webpage, identifying information may include, where available, a study title, author, journal, DOI, PMID, publication date, account-related information, file identifier, report identifier, URL, or other information reasonably sufficient for MedQuiry to identify the material.

4. Contact information. Information reasonably sufficient to permit MedQuiry to contact the complaining party, such as the complaining party's name, mailing address, telephone number, and, if available, email address.

5. Good-faith statement. A statement that the complaining party has a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law.

6. Accuracy and authority statement. A statement that the information in the notification is accurate and, under penalty of perjury, that the complaining party is authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.

A notification that does not substantially comply with applicable statutory requirements may be ineffective under the DMCA and may delay MedQuiry's ability to investigate or respond.

MedQuiry may contact a complaining party to request information reasonably necessary to complete or clarify a notice.

7. MEDQUIRY'S RESPONSE TO COPYRIGHT NOTICES

Upon receiving a notification of claimed infringement, MedQuiry may take actions that it reasonably determines are appropriate under the circumstances and applicable law.

Such actions may include:

• reviewing the notification for substantial compliance with applicable requirements;
• requesting additional information;
• identifying the material at issue;
• investigating relevant account or storage records;
• removing or disabling access to material;
• quarantining material;
• declining to process or retain material;
• notifying the user or customer that submitted the material;
• preserving records reasonably necessary for legal, security, or evidentiary purposes;
• restricting or suspending an account;
• terminating an account in appropriate circumstances;
• responding to a valid counter-notification; or
• taking other action permitted or required by applicable law.

Where applicable under the DMCA, MedQuiry will act expeditiously to remove or disable access to material upon obtaining the legally sufficient notification, knowledge, or awareness requiring such action under the applicable DMCA framework. Review or investigation will not be used to delay action required under that framework.

Removal or disabling of material does not constitute a determination by MedQuiry that copyright infringement has occurred.

Similarly, MedQuiry's decision not to remove material does not constitute a determination that the material is non-infringing.

MedQuiry is not a court and does not adjudicate ownership of copyrights or resolve complex disputes concerning fair use, licenses, authorship, ownership, contractual rights, or other defenses.

Investigations and enforcement are subject to applicable law, the Privacy Notice, and the Agreement. They do not authorize access to or use of stored studies beyond the limited purposes stated in the Terms and any applicable API or enterprise agreement. Applicable contractual notice, cure, suspension, and termination requirements continue to govern, except to the extent immediate action is permitted or required by applicable law and the Agreement.

8. NOTICE TO THE AFFECTED USER

Where MedQuiry removes or disables access to material residing on its systems at the direction of a user or customer under the process addressed in 17 U.S.C. § 512(g), MedQuiry will take reasonable steps promptly to notify the affected user or customer. In other circumstances, MedQuiry may provide notice as required or appropriate under applicable law and the Agreement.

The notice may include information concerning:

• the material affected;
• the fact that access has been removed or disabled;
• the basis for MedQuiry's action;
• information received from the complaining party as legally appropriate; and
• the process for submitting a counter-notification.

Subject to applicable law and the notification requirements of the applicable DMCA procedure, MedQuiry may withhold information where disclosure would violate law, compromise security, interfere with an investigation, or expose confidential information. Disclosures will be limited to information reasonably necessary for the procedure or another lawful purpose.

9. DMCA COUNTER-NOTIFICATIONS

If material that you submitted was removed or access to it was disabled as a result of a DMCA notification and you believe the material was removed or disabled because of mistake or misidentification, you may submit a written counter-notification to MedQuiry's designated Copyright Agent.

To be effective under 17 U.S.C. § 512(g)(3), a counter-notification should include substantially all of the following:

1. Signature. Your physical or electronic signature.

2. Identification of material. Identification of the material that has been removed or to which access has been disabled and the location at which the material appeared or was stored before it was removed or access was disabled.

3. Statement under penalty of perjury. A statement, under penalty of perjury, that you have a good-faith belief that the material was removed or disabled as a result of mistake or misidentification of the material to be removed or disabled.

4. Contact and jurisdiction information. Your name, address, and telephone number, together with a statement that you consent to the jurisdiction of the Federal District Court for the judicial district in which your address is located or, if your address is outside the United States, to the jurisdiction of any Federal District Court in which the service provider may be found, and that you will accept service of process from the person who submitted the original notification of claimed infringement or an agent of that person.

Counter-notifications should be sent to MedQuiry's designated Copyright Agent identified in Section 5.

When a valid counter-notification is processed under 17 U.S.C. § 512(g), MedQuiry will provide a copy to the person who submitted the original notification, including the identifying and contact information required for the counter-notification. Do not include unnecessary sensitive information. Handling of personal information is subject to Section 17, the Privacy Notice, and applicable law.

Do not submit a counter-notification unless you have a good-faith basis for doing so.

10. RESTORATION FOLLOWING A COUNTER-NOTIFICATION

Where MedQuiry follows the procedure in 17 U.S.C. § 512(g), upon receiving a valid counter-notification it will promptly provide a copy to the person who submitted the original notification.

MedQuiry will inform that person that it will replace the removed material or cease disabling access to it in ten (10) business days, subject to the conditions described below.

Under that procedure, MedQuiry will restore the material or cease disabling access to it not less than ten (10) and not more than fourteen (14) business days after receiving a valid counter-notification, unless its designated agent first receives notice that the original complaining party has filed an action seeking a court order restraining the affected user from engaging in infringing activity relating to the material on MedQuiry’s system or network.

Nothing in this Section requires MedQuiry to restore material that is independently prohibited under the Agreement, including material that:

• violates the Acceptable Use Policy;
• violates applicable law;
• contains prohibited information;
• creates a security risk;
• violates contractual or institutional restrictions;
• infringes rights other than those addressed by the applicable counter-notification; or
• otherwise provides an independent lawful basis for removal or restriction.

11. REPEAT INFRINGER POLICY

MedQuiry has adopted and will reasonably implement a policy providing for termination, in appropriate circumstances, of users, subscribers, customers, or account holders who are repeat infringers. This Policy informs users and account holders of that policy.

MedQuiry may suspend, restrict, or terminate an account or access to the Services when MedQuiry reasonably determines, based on the facts and circumstances, that the user or account holder has repeatedly infringed copyrights or other intellectual property rights.

In administering this policy, MedQuiry may consider factors including:

• the number and nature of infringement notices associated with the account;
• whether notices were facially or legally valid;
• whether counter-notifications were submitted;
• whether challenged material was restored;
• whether a court has determined that infringement occurred;
• the user's response to prior warnings or enforcement actions;
• evidence of knowing, willful, systematic, or commercial infringement;
• attempts to evade previous enforcement measures;
• whether different notices concern the same or different copyrighted works;
• whether an enterprise customer took reasonable corrective action concerning an Authorized User; and
• other facts MedQuiry reasonably considers relevant.

MedQuiry does not treat the mere receipt of an unsupported complaint as conclusive proof that infringement occurred.

Nothing in this Policy limits MedQuiry's right to suspend or terminate an account after a single incident when the conduct independently justifies such action under the Agreement or applicable law.

12. STANDARD TECHNICAL MEASURES

To the extent required for eligibility under applicable provisions of 17 U.S.C. § 512, MedQuiry will accommodate and will not interfere with standard technical measures used by copyright owners to identify or protect copyrighted works, as that term is defined by applicable law.

Nothing in this Section requires MedQuiry to implement measures that do not constitute "standard technical measures" within the meaning of the DMCA.

13. KNOWING MISREPRESENTATIONS

The DMCA provides potential liability for knowingly making certain material misrepresentations in connection with copyright notifications or counter-notifications.

Accordingly, you should not submit a notification claiming that material or activity is infringing unless you have a good-faith basis for the claim.

You likewise should not submit a counter-notification claiming that material was removed or disabled because of mistake or misidentification unless you have a good-faith basis for that assertion.

MedQuiry reserves all rights and remedies concerning fraudulent, abusive, deceptive, or knowingly false submissions.

14. OTHER INTELLECTUAL PROPERTY COMPLAINTS

The DMCA notice-and-counter-notice procedures described above relate specifically to copyright.

Complaints concerning other intellectual property or proprietary rights—including trademarks, trade secrets, database rights, rights of publicity, contractual restrictions, or similar claims—may be sent to:

The Senior Wellness Company

MedQuiry

P.O. Box 24

Califon, New Jersey 07830

Email: legal@medquiry.com

A complaint concerning non-copyright rights should provide sufficient information for MedQuiry to understand the claim, identify the material or activity at issue, identify the asserted rights, and contact the complaining party.

MedQuiry may investigate and respond to such complaints in its discretion and as required by applicable law or contractual obligations.

The submission of a non-copyright intellectual property complaint does not create DMCA rights, obligations, or procedures where the DMCA does not otherwise apply.

15. NO OBLIGATION TO MONITOR

Except as required by applicable law or an applicable written agreement, MedQuiry does not undertake a general obligation to monitor User Content, Customer Content, Stored Study PDFs, Personal Lockers, or other materials submitted to or stored through the Services for possible copyright infringement.

Acceptance, processing, scoring, retention, or storage of material does not constitute MedQuiry's:

• approval of the material;
• verification of ownership;
• determination of copyright status;
• determination that the user's submission is authorized;
• endorsement of the material; or
• waiver of any right to remove or restrict the material later.

16. REMOVAL INDEPENDENT OF THE DMCA

MedQuiry reserves the right, subject to applicable law and any applicable written agreement, to remove, disable access to, quarantine, reject, or refuse to process or retain material for reasons independent of a DMCA notification.

Such reasons may include material that:

• violates the Terms of Service;
• violates the Acceptable Use Policy;
• infringes or appears to infringe third-party rights;
• is unlawful;
• is subject to unauthorized access or licensing restrictions;
• contains prohibited or regulated information;
• threatens the security or integrity of the Services; or
• otherwise creates material legal, security, contractual, or operational risk.

MedQuiry's exercise of these rights does not constitute an admission concerning copyright ownership or infringement.

17. PRESERVATION, RETENTION, AND PERSONAL INFORMATION

Removal or disabling of access under this Policy is distinct from deletion from active systems and the expiration of backup copies. Stored study PDFs generally remain available until the user or customer deletes them, requests deletion where applicable, or the relevant account or project is closed, subject to applicable law, the Privacy Notice, and any applicable separately executed agreement. A copy of the text extracted from each scored study is retained, linked to its score report, for re-scoring and internal quality assurance, and is deleted when that report is deleted. Temporary technical copies may remain for limited periods in encrypted backups, disaster-recovery systems, caches, or security records until overwritten or deleted through lawful retention cycles.

MedQuiry may preserve limited information reasonably necessary to comply with law or legal process, preserve evidence, investigate misuse, resolve disputes, maintain security, enforce agreements, or establish, exercise, or defend legal claims. Retention must comply with applicable law, the Privacy Notice, and any applicable data-processing agreement. An investigation, suspension, termination, infringement notice, or counter-notification does not itself authorize indefinite retention of submitted or stored studies or waive applicable privacy rights. Account closure, dormancy, deletion notices, and treatment of unused tokens remain governed by the Terms and applicable account-lifecycle disclosures.

Limited technical or legally preserved copies do not mean that removed material remains available through ordinary service functionality. When an account is deleted, MedQuiry will delete or de-identify account-linked information no longer reasonably necessary, including stored study PDFs, subject to lawful retention exceptions. Where MedQuiry acts as processor, required return or deletion and assistance with individual rights are governed by mandatory law and the applicable data-processing agreement.

Copyright complaints and counter-notifications may contain names, signatures, contact details, account or file identifiers, correspondence, and supporting information. MedQuiry processes that information to administer the complaint procedure, communicate with the parties, investigate misuse, protect rights, maintain necessary records, and address legal claims or legal process. The Privacy Notice governs applicable legal bases, recipients, safeguards, retention, and international transfers. A foreign legal requirement does not automatically establish a lawful basis under the GDPR.

MedQuiry may disclose information to the affected user or customer, the complaining party, authorized enterprise administrators, authorized service providers and professional advisors, or courts and authorities, only as necessary and legally permitted or required. A copy of a valid counter-notification is sent to the original complaining party under the procedure in Section 10. A complaint does not by itself authorize unrestricted disclosure of a private account, Personal Locker, or its contents. Required safeguards for international transfers of personal data remain applicable.

The Senior Wellness Company’s controller or processor role depends on the processing activity, as described in the Privacy Notice and any applicable data-processing agreement. Contractual licenses, acceptance of this Policy, and continued use of the Services do not substitute for a lawful basis or legally required consent. Where required, binding processor terms must be in place; this Policy does not replace them.

Individuals may exercise applicable rights of access, rectification, erasure, restriction, objection, portability, or withdrawal of consent, subject to legal conditions and exceptions. Privacy requests may be sent to privacy@medquiry.com or submitted through an available privacy-request mechanism. MedQuiry will respond within legally required periods and provide required assistance where it acts as processor. Neither technical deletion functionality nor a copyright dispute limits a statutory privacy right. Nothing in this Policy restricts a non-waivable right to complain to a competent supervisory authority or pursue an available remedy; contacting MedQuiry first is not a prerequisite.

18. RELATIONSHIP TO THE AGREEMENT

This Policy supplements the Agreement governing use of the Services.

Nothing in this Policy:

• expands any license granted to a user or customer;
• expands MedQuiry's rights in User Content or Customer Content;
• transfers ownership of third-party publications to MedQuiry;
• limits MedQuiry's proprietary rights in the MedQuiry Technology;
• creates a warranty that submitted material is non-infringing;
• creates an obligation to adjudicate copyright disputes;
• prevents MedQuiry from complying with court orders or lawful governmental requests; or
• limits any right or remedy otherwise available under the Agreement or applicable law.

In the event of a conflict, the applicable Agreement’s order of precedence governs. A separately executed agreement controls only with respect to the specific subject matter it addresses; a data-processing agreement or Business Associate Agreement controls solely with respect to its subject matter. Consistent with Article 13 of the Terms, this Policy controls a conflict with that Article concerning copyright notification or counter-notification procedures. The Privacy Notice governs personal-information practices, subject to applicable law and any applicable separately executed data-processing agreement. Mandatory legal requirements control notwithstanding any contractual order of precedence. Nothing in this Policy waives, restricts, or excludes a right or remedy that cannot lawfully be waived under the GDPR or other applicable law.

MedQuiry’s rights in its technology, scoring methodology, MedQuiry Scores, Analytical Outputs, and API Outputs, and users’ permitted use and attribution obligations, remain governed by the Agreement. This Policy does not restrict accurate academic citation, legitimate scholarly discussion, criticism, academic debate, or fair commentary permitted by Sections 8.9 and 8.11 of the Terms and applicable law, or expand authorized redistribution rights. Ownership of outputs does not transfer ownership of the underlying study to MedQuiry.

19. CHANGES TO THIS POLICY

MedQuiry may update this Policy from time to time to reflect changes in:

• applicable law;
• Copyright Office rules or procedures;
• the Services;
• MedQuiry's copyright-compliance procedures; or
• business, operational, security, or legal requirements.

The effective date stated at the beginning of this Policy identifies the date of the then-current version.

Material changes will become effective after reasonable notice through the Services, by email where appropriate, or by another reasonable method, consistent with Section 18.2 of the Terms and any applicable executed agreement. Email notices are effective when sent, except where applicable law requires a different method or timing. Urgent measures concerning security, legal compliance, abuse, or third-party rights may be implemented immediately only as permitted by applicable law and the Agreement. Required notice, consent, and contractual amendment procedures remain applicable. Continued use after an update constitutes acceptance only to the extent permitted by applicable law and the Agreement; it does not substitute for required consent, waive non-waivable rights, or expand rights in submitted or stored study contents.

20. CONTACT INFORMATION

Questions concerning this Policy that do not constitute formal DMCA notifications may be directed to:

The Senior Wellness Company

MedQuiry

P.O. Box 24

Califon, New Jersey 07830

Email: legal@medquiry.com

Formal notifications of claimed copyright infringement and DMCA counter-notifications should be sent to Richard O’Neill, the Designated Copyright Agent identified in Section 5. Privacy inquiries and privacy-rights requests should be sent to privacy@medquiry.com. General legal correspondence should be sent to legal@medquiry.com.

END OF COPYRIGHT AND DMCA POLICY